Search
IRadimed Corp
IRMDAdd to Watchlist
86.440USD
-0.250-0.29%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
1.10BMarket Cap
46.64P/E TTM
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-0.29%
5 Days
+0.18%
1 Month
-5.92%
6 Months
+3.01%
Year to Date
-11.14%
1 Year
+61.17%
TradingKey Stock Score of IRadimed Corp
Currency: USD Updated: 2026-05-15Key Insights
IRadimed Corp's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 30 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 118.67.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
IRadimed Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
IRadimed Corp Highlights
StrengthsRisks
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 27.84% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 83.81M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 83.81M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 29.64%.
Overvalued
The company’s latest PE is 46.64, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 8.32M shares, decreasing 5.17% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 65.00 shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.89.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
118.667
Target Price
+36.57%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
IRadimed Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
IRadimed Corp Info
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
Ticker SymbolIRMD
CompanyIRadimed Corp
CEOSusi (Roger)
Websitehttps://www.iradimed.com/
Related Instruments
-1.32%
-2.23%
-1.62%
-0.49%
-1.30%
+0.41%
-1.57%
-1.05%
-2.22%
-1.04%
-1.59%
-3.29%
-1.06%
-6.97%
+0.04%
-0.76%
-0.71%
+1.31%
-1.21%
-0.56%Popular Instruments
102.160
+3.297 (+3.33%)
300.230
+2.020 (+0.68%)
225.320
-10.420 (-4.42%)
4538.710
-111.520 (-2.40%)
482.020
-7.101 (-1.45%)
1407.610
+24.890 (+1.80%)
724.660
-51.350 (-6.62%)
396.780
-4.290 (-1.07%)
78085.600
-145.400 (-0.19%)
422.240
-21.060 (-4.75%)
